Header Logo

Ajaypal Singh

Concepts (540)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Anemia
58
2023
94
15.880
Why?
Hematinics
47
2023
49
14.240
Why?
Renal Insufficiency, Chronic
37
2023
88
13.530
Why?
Erythropoietin
42
2023
49
11.010
Why?
Hemoglobins
43
2023
78
6.990
Why?
Kidney Diseases
26
2019
109
6.460
Why?
Renal Dialysis
38
2023
123
6.400
Why?
Kidney Failure, Chronic
30
2019
165
5.940
Why?
Tomography, X-Ray Computed
26
2019
730
4.310
Why?
Darbepoetin alfa
19
2023
19
3.210
Why?
Humans
157
2023
28436
2.710
Why?
Prolyl-Hydroxylase Inhibitors
4
2022
4
2.480
Why?
Epoetin Alfa
19
2022
21
2.240
Why?
Kidney
11
2019
175
2.210
Why?
Blast Injuries
5
2016
5
2.090
Why?
Barbiturates
5
2023
6
1.840
Why?
Middle Aged
64
2022
9269
1.770
Why?
Glycine
3
2022
12
1.730
Why?
Male
79
2022
15291
1.670
Why?
Female
79
2023
15730
1.630
Why?
Diabetes Mellitus, Type 2
10
2023
191
1.600
Why?
Randomized Controlled Trials as Topic
9
2013
330
1.570
Why?
Recombinant Proteins
22
2022
213
1.520
Why?
Cardiovascular Diseases
16
2022
372
1.480
Why?
Terrorism
5
2016
14
1.320
Why?
Iron
7
2023
21
1.270
Why?
Aged
51
2022
9277
1.270
Why?
Magnetic Resonance Imaging
8
2020
1143
1.210
Why?
Anemia, Iron-Deficiency
4
2015
5
1.210
Why?
Adult
40
2023
8107
1.160
Why?
Heart Failure
10
2019
180
1.120
Why?
Nephrology
4
2019
15
1.090
Why?
Mass Screening
3
2014
183
1.070
Why?
Foreign Bodies
3
2015
30
1.070
Why?
Chronic Disease
16
2010
441
1.020
Why?
Risk Factors
23
2020
2408
1.000
Why?
Clinical Trials as Topic
2
2022
239
0.980
Why?
Neoplasms
3
2023
239
0.970
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2022
61
0.920
Why?
Lupus Nephritis
4
2006
32
0.920
Why?
Diabetic Nephropathies
5
2019
22
0.920
Why?
Treatment Outcome
25
2023
3615
0.910
Why?
Biopsy, Needle
3
2012
108
0.910
Why?
Multiple Trauma
4
2016
4
0.880
Why?
Benzhydryl Compounds
1
2023
4
0.860
Why?
Buprenorphine
1
2023
6
0.860
Why?
Opioid-Related Disorders
1
2023
59
0.780
Why?
Liver Transplantation
3
2015
96
0.770
Why?
Kidney Transplantation
4
2009
133
0.770
Why?
Bone Diseases, Metabolic
3
2016
20
0.760
Why?
Prevalence
11
2018
468
0.750
Why?
Hypoxia-Inducible Factor-Proline Dioxygenases
4
2022
5
0.750
Why?
Endoscopy
2
2015
183
0.740
Why?
Vitamin D
3
2013
41
0.720
Why?
Farmers
1
2020
1
0.720
Why?
Colitis
3
2005
37
0.720
Why?
Occupational Exposure
1
2020
17
0.710
Why?
United States Food and Drug Administration
3
2010
22
0.700
Why?
Metabolic Syndrome
2
2013
62
0.700
Why?
Prognosis
9
2017
825
0.690
Why?
Erythropoiesis
4
2023
5
0.690
Why?
Stroke
9
2021
276
0.680
Why?
Practice Guidelines as Topic
7
2012
319
0.680
Why?
Myocardium
1
2020
104
0.680
Why?
Pandemics
1
2022
260
0.660
Why?
Hypertension
6
2018
246
0.650
Why?
Glomerular Filtration Rate
8
2016
53
0.640
Why?
Retrospective Studies
17
2023
3612
0.640
Why?
Myocardial Infarction
5
2021
145
0.640
Why?
Acute Kidney Injury
3
2014
47
0.610
Why?
Fasciitis, Necrotizing
1
2018
6
0.600
Why?
Lower Extremity
1
2018
39
0.590
Why?
Risk Assessment
12
2019
677
0.590
Why?
Ferric Compounds
4
2015
8
0.580
Why?
Marijuana Smoking
1
2017
3
0.560
Why?
Head Injuries, Penetrating
1
2017
1
0.550
Why?
Wounds, Gunshot
1
2017
4
0.550
Why?
Boston
6
2016
27
0.550
Why?
Cytokines
2
2008
230
0.550
Why?
Certification
2
2019
49
0.550
Why?
Contrast Media
6
2019
75
0.540
Why?
Ferritins
5
2017
9
0.540
Why?
Proteinuria
4
2013
58
0.540
Why?
Pathology
1
2016
2
0.530
Why?
Evidence-Based Medicine
4
2010
196
0.520
Why?
Societies, Medical
2
2019
154
0.520
Why?
Warfare
1
2016
14
0.510
Why?
Triage
1
2016
21
0.510
Why?
Cholangiocarcinoma
1
2015
4
0.510
Why?
Abdominal Injuries
1
2015
5
0.510
Why?
Renal Replacement Therapy
2
2015
23
0.510
Why?
Bile Duct Neoplasms
1
2015
6
0.510
Why?
Biliary Fistula
2
2006
7
0.500
Why?
Pelvis
1
2015
31
0.500
Why?
Saudi Arabia
6
2016
8
0.490
Why?
Predictive Value of Tests
8
2020
492
0.490
Why?
Neck Injuries
1
2015
4
0.490
Why?
Craniocerebral Trauma
1
2015
7
0.490
Why?
Education, Medical, Graduate
1
2016
77
0.490
Why?
Medicare
4
2010
121
0.480
Why?
Adolescent
12
2016
2307
0.480
Why?
Gastrostomy
1
2015
10
0.480
Why?
Jejunostomy
1
2015
9
0.480
Why?
Consanguinity
2
2014
6
0.470
Why?
United States
11
2017
2201
0.470
Why?
Radiography, Interventional
3
2012
23
0.460
Why?
Diagnostic Imaging
1
2015
80
0.460
Why?
Hypertension, Renal
1
2014
3
0.450
Why?
Death, Sudden, Cardiac
1
2014
14
0.450
Why?
Acute Disease
6
2017
208
0.450
Why?
Ventricular Fibrillation
1
2014
15
0.440
Why?
India
4
2020
22
0.440
Why?
Cost of Illness
1
2014
53
0.440
Why?
Vitamin D Deficiency
1
2013
11
0.430
Why?
Pediatrics
1
2013
46
0.420
Why?
Heart Arrest
1
2014
41
0.420
Why?
Biomedical Research
1
2013
66
0.420
Why?
Diagnosis, Differential
9
2019
372
0.410
Why?
Research Design
4
2008
207
0.410
Why?
Kidney Tubules
2
2009
8
0.400
Why?
Disease Outbreaks
1
2012
82
0.400
Why?
Platelet Activation
1
2012
2
0.400
Why?
Child
8
2016
1420
0.400
Why?
Splenic Diseases
1
2012
3
0.390
Why?
Blood Platelets
1
2012
39
0.390
Why?
Tissue Donors
3
2015
84
0.390
Why?
Spleen
1
2012
34
0.390
Why?
Intention to Treat Analysis
2
2021
8
0.390
Why?
Testis
2
2018
12
0.380
Why?
Abdomen, Acute
3
2008
5
0.380
Why?
Injections, Subcutaneous
3
2010
25
0.380
Why?
Fanconi Syndrome
1
2011
1
0.380
Why?
Red-Cell Aplasia, Pure
2
2008
2
0.380
Why?
Multiple Myeloma
1
2011
21
0.380
Why?
Surgery, Computer-Assisted
1
2012
51
0.370
Why?
Appendicitis
2
2008
18
0.370
Why?
Mass Casualty Incidents
3
2016
9
0.370
Why?
Cross-Sectional Studies
6
2020
933
0.370
Why?
Liver
2
2015
160
0.370
Why?
Bombs
3
2015
3
0.360
Why?
Drug Approval
1
2010
7
0.350
Why?
Preoperative Care
4
2015
125
0.350
Why?
Prospective Studies
9
2022
1809
0.350
Why?
Biliary Tract Diseases
1
2010
6
0.340
Why?
Reimbursement Mechanisms
1
2010
12
0.340
Why?
Vascular Diseases
1
2010
44
0.330
Why?
Magnetic Resonance Spectroscopy
2
2020
41
0.330
Why?
Aged, 80 and over
11
2017
4857
0.330
Why?
Liver Diseases
1
2010
35
0.330
Why?
Early Diagnosis
4
2014
67
0.320
Why?
Calcium Compounds
1
2009
2
0.320
Why?
Minerals
1
2009
6
0.320
Why?
Bone Density Conservation Agents
1
2009
14
0.320
Why?
Glomerulosclerosis, Focal Segmental
1
2009
35
0.320
Why?
Kidney Glomerulus
1
2009
48
0.310
Why?
Dose-Response Relationship, Drug
5
2013
351
0.310
Why?
Needles
1
2008
21
0.310
Why?
Endothelium, Vascular
1
2008
49
0.310
Why?
Cost Savings
1
2008
36
0.310
Why?
Muscle Neoplasms
1
2008
5
0.310
Why?
Pelvic Pain
1
2008
13
0.300
Why?
Abdominal Muscles
1
2008
7
0.300
Why?
Immunologic Factors
1
2008
34
0.300
Why?
Hospital Mortality
2
2014
147
0.300
Why?
Phosphates
1
2008
22
0.300
Why?
Data Interpretation, Statistical
1
2008
83
0.300
Why?
Abdominal Abscess
1
2008
3
0.300
Why?
Nephritis, Interstitial
2
2008
7
0.300
Why?
Acute Coronary Syndrome
1
2008
16
0.300
Why?
Calculi
1
2008
4
0.300
Why?
Appendectomy
1
2008
16
0.300
Why?
Bone and Bones
1
2009
118
0.300
Why?
Carcinoma, Renal Cell
1
2008
48
0.290
Why?
Multicenter Studies as Topic
2
2007
51
0.290
Why?
Cholangiopancreatography, Magnetic Resonance
2
2019
4
0.290
Why?
Drainage
3
2015
50
0.280
Why?
Diabetic Angiopathies
2
2019
6
0.280
Why?
Age Factors
4
2020
781
0.280
Why?
Drug-Related Side Effects and Adverse Reactions
1
2007
21
0.280
Why?
Pancreatic Fistula
1
2006
3
0.280
Why?
Ascites
1
2006
4
0.270
Why?
Diabetes Complications
1
2007
59
0.270
Why?
Biopsy
5
2019
220
0.270
Why?
Algorithms
4
2016
377
0.270
Why?
Tissue and Organ Procurement
1
2006
35
0.260
Why?
Inflammation
1
2008
284
0.260
Why?
Penile Neoplasms
1
2005
2
0.250
Why?
Severity of Illness Index
5
2012
988
0.250
Why?
Hernia, Abdominal
1
2005
2
0.250
Why?
Iron Compounds
1
2005
1
0.240
Why?
Metabolic Diseases
1
2005
10
0.240
Why?
Intestinal Fistula
1
2004
5
0.230
Why?
Gallbladder Diseases
1
2004
5
0.230
Why?
Colonic Diseases
1
2004
10
0.230
Why?
Pancreaticoduodenectomy
1
2004
15
0.230
Why?
Fertility
1
2004
19
0.230
Why?
Infertility
1
2004
8
0.230
Why?
Mesenteric Vascular Occlusion
1
2004
4
0.230
Why?
Glomerulonephritis
1
2004
20
0.230
Why?
Immunosuppressive Agents
2
2009
140
0.230
Why?
Omentum
1
2004
8
0.230
Why?
Cohort Studies
7
2014
1926
0.230
Why?
Cyclophosphamide
1
2004
51
0.230
Why?
Ovary
1
2004
21
0.230
Why?
Infarction
1
2004
30
0.230
Why?
Double-Blind Method
8
2022
433
0.220
Why?
Granuloma
1
2003
15
0.220
Why?
Comorbidity
3
2013
500
0.220
Why?
Ibuprofen
1
2003
12
0.220
Why?
Albuminuria
1
2023
14
0.220
Why?
Radiographic Image Enhancement
1
2004
27
0.220
Why?
Cholelithiasis
1
2003
9
0.220
Why?
Gastric Outlet Obstruction
1
2003
3
0.220
Why?
Nurse's Role
1
2005
128
0.220
Why?
Opiate Substitution Treatment
1
2023
6
0.220
Why?
Narcotic Antagonists
1
2023
10
0.220
Why?
Incidence
3
2017
773
0.220
Why?
Glucosides
1
2023
2
0.220
Why?
Patient Education as Topic
3
2010
160
0.210
Why?
Hyperparathyroidism, Secondary
2
2016
3
0.210
Why?
Survival Analysis
3
2009
267
0.210
Why?
Patients
1
2023
35
0.210
Why?
Catheter Ablation
2
2015
73
0.210
Why?
Gastroenterology
1
2022
10
0.200
Why?
Inflammatory Bowel Diseases
1
2004
88
0.200
Why?
Young Adult
5
2018
2069
0.200
Why?
Colonic Polyps
1
2022
34
0.190
Why?
Survival Rate
3
2014
356
0.190
Why?
Data Collection
1
2022
98
0.190
Why?
Models, Biological
1
2003
326
0.190
Why?
Logistic Models
2
2020
396
0.190
Why?
Injections, Intravenous
4
2008
31
0.180
Why?
Tobacco, Smokeless
1
2020
1
0.180
Why?
Disease Progression
4
2017
717
0.180
Why?
Confidence Intervals
3
2012
95
0.180
Why?
Child, Preschool
4
2016
688
0.180
Why?
Analgesics, Opioid
1
2023
216
0.180
Why?
Quality of Life
5
2023
661
0.180
Why?
Time Factors
5
2018
1491
0.170
Why?
International Cooperation
2
2019
24
0.170
Why?
Alcohol Drinking
1
2020
80
0.170
Why?
Hospitalization
4
2017
323
0.170
Why?
Pathologists
1
2019
1
0.170
Why?
Pathology, Clinical
1
2019
1
0.170
Why?
Mitochondrial Proteins
1
2019
42
0.170
Why?
Catheterization
2
2012
45
0.160
Why?
C-Reactive Protein
2
2017
104
0.160
Why?
Intracellular Signaling Peptides and Proteins
1
2019
53
0.160
Why?
Administration, Oral
1
2019
111
0.160
Why?
Choledocholithiasis
1
2019
2
0.160
Why?
Deglutition Disorders
1
2019
35
0.160
Why?
Lupus Erythematosus, Systemic
1
2002
192
0.160
Why?
Running
2
2016
16
0.160
Why?
Metformin
1
2019
20
0.160
Why?
Hydroxamic Acids
1
2018
5
0.160
Why?
Histone Deacetylase Inhibitors
1
2018
8
0.160
Why?
Metabolomics
1
2018
17
0.160
Why?
Ultrasonography, Interventional
2
2012
76
0.160
Why?
Anterior Wall Myocardial Infarction
1
2018
1
0.150
Why?
Myositis
1
2019
34
0.150
Why?
Leiomyoma
2
2008
7
0.150
Why?
Autoimmune Diseases
1
2019
48
0.150
Why?
Fractures, Closed
1
2018
1
0.150
Why?
Foot Injuries
1
2018
1
0.150
Why?
Health Knowledge, Attitudes, Practice
2
2010
185
0.150
Why?
ST Elevation Myocardial Infarction
1
2018
9
0.150
Why?
Ankle Injuries
1
2018
9
0.150
Why?
Health Literacy
1
2020
109
0.150
Why?
Radiation Injuries
1
2018
32
0.150
Why?
Drug Costs
2
2008
13
0.150
Why?
Up-Regulation
2
2010
177
0.150
Why?
Biosimilar Pharmaceuticals
1
2017
3
0.150
Why?
Ultrasonography
2
2018
243
0.150
Why?
Practice Patterns, Physicians'
2
2010
122
0.150
Why?
Patient Selection
2
2010
206
0.140
Why?
Sex Distribution
2
2018
82
0.140
Why?
Nephrologists
1
2017
4
0.140
Why?
Glasgow Coma Scale
1
2017
9
0.140
Why?
Antihypertensive Agents
1
2017
81
0.140
Why?
Sensitivity and Specificity
5
2018
517
0.140
Why?
Follow-Up Studies
6
2014
1859
0.140
Why?
Cognition Disorders
2
2014
1003
0.140
Why?
Executive Function
2
2014
115
0.130
Why?
Public Health
1
2017
70
0.130
Why?
Blood Pressure
1
2017
208
0.130
Why?
Coronary Artery Disease
1
2018
141
0.130
Why?
Emergency Service, Hospital
1
2019
259
0.130
Why?
Explosions
1
2016
1
0.130
Why?
Pilot Projects
3
2017
440
0.130
Why?
Drug Monitoring
2
2006
18
0.130
Why?
Radiography
1
2018
640
0.130
Why?
Program Development
1
2016
64
0.130
Why?
Photochemotherapy
1
2015
5
0.130
Why?
Cholangiopancreatography, Endoscopic Retrograde
1
2015
11
0.130
Why?
Muscle, Skeletal
1
2019
397
0.130
Why?
Endosonography
1
2015
13
0.130
Why?
Diphosphates
1
2015
1
0.130
Why?
Dialysis Solutions
1
2015
5
0.120
Why?
Risk Reduction Behavior
3
2011
46
0.120
Why?
Trauma Centers
1
2015
9
0.120
Why?
Radiopharmaceuticals
2
2007
53
0.120
Why?
Endoscopy, Digestive System
1
2015
8
0.120
Why?
Intensive Care Units, Pediatric
1
2014
14
0.120
Why?
Wounds, Penetrating
1
2014
7
0.120
Why?
Curriculum
1
2016
164
0.120
Why?
Corneal Opacity
1
2014
2
0.120
Why?
Acidosis, Renal Tubular
1
2014
2
0.120
Why?
Sex Factors
2
2013
476
0.110
Why?
Enteral Nutrition
1
2015
65
0.110
Why?
Electric Countershock
1
2014
11
0.110
Why?
Kidney Function Tests
2
2017
22
0.110
Why?
Defibrillators, Implantable
1
2014
12
0.110
Why?
Pedigree
1
2013
67
0.110
Why?
Diabetes Mellitus
2
2018
137
0.110
Why?
Coronary Angiography
1
2014
83
0.110
Why?
Kaplan-Meier Estimate
3
2012
179
0.110
Why?
Cardiopulmonary Resuscitation
1
2014
21
0.110
Why?
Chi-Square Distribution
2
2010
146
0.110
Why?
Animals
3
2018
3780
0.110
Why?
Blood Viscosity
1
2013
10
0.110
Why?
Critical Care
1
2016
199
0.110
Why?
Electrocardiography
1
2014
119
0.110
Why?
Age Distribution
1
2013
89
0.110
Why?
Middle East
1
2012
5
0.100
Why?
Regression Analysis
2
2012
266
0.100
Why?
Calcinosis
2
2014
49
0.100
Why?
P-Selectin
1
2012
2
0.100
Why?
CD40 Ligand
1
2012
8
0.100
Why?
Cell-Derived Microparticles
1
2012
8
0.100
Why?
Splenic Artery
1
2012
1
0.100
Why?
Sclerosing Solutions
1
2012
2
0.100
Why?
Sclerotherapy
1
2012
4
0.100
Why?
Magnetic Resonance Imaging, Interventional
1
2012
9
0.100
Why?
Pneumothorax
1
2012
11
0.100
Why?
Aneurysm, False
1
2012
7
0.100
Why?
Population Surveillance
1
2012
110
0.100
Why?
Spermatozoa
2
2018
9
0.100
Why?
Postoperative Hemorrhage
1
2012
24
0.100
Why?
Thrombosis
2
2017
58
0.100
Why?
Drug Therapy, Combination
3
2008
183
0.090
Why?
Microscopy, Electron
1
2011
67
0.090
Why?
Bone Marrow Transplantation
1
2011
26
0.090
Why?
Risk
2
2010
205
0.090
Why?
Embolization, Therapeutic
1
2012
60
0.090
Why?
Multivariate Analysis
4
2015
331
0.090
Why?
Ethanol
1
2012
120
0.090
Why?
Calcium
2
2016
381
0.090
Why?
Hepatectomy
1
2011
64
0.090
Why?
Iron, Dietary
1
2010
1
0.090
Why?
Ferrosoferric Oxide
1
2010
1
0.090
Why?
Hepcidins
1
2010
1
0.090
Why?
Indicators and Reagents
1
2010
12
0.090
Why?
Antimicrobial Cationic Peptides
1
2010
3
0.090
Why?
Cardiac Output
1
2010
14
0.090
Why?
Immunohistochemistry
1
2011
362
0.090
Why?
Awareness
1
2010
45
0.090
Why?
Glomerulonephritis, Membranous
1
2010
6
0.090
Why?
Case-Control Studies
2
2011
594
0.090
Why?
Drug Labeling
1
2010
2
0.090
Why?
Consumer Product Safety
1
2010
6
0.090
Why?
Health Care Reform
1
2010
15
0.080
Why?
Erythrocytes
1
2009
20
0.080
Why?
Feasibility Studies
1
2010
232
0.080
Why?
Developing Countries
1
2009
14
0.080
Why?
Truth Disclosure
1
2009
7
0.080
Why?
Global Health
1
2009
42
0.080
Why?
Antineoplastic Agents
1
2011
190
0.080
Why?
Hematocrit
1
2009
16
0.080
Why?
Length of Stay
2
2014
329
0.080
Why?
Parent-Child Relations
1
2009
40
0.080
Why?
Sirolimus
1
2009
20
0.080
Why?
Massachusetts
1
2009
19
0.080
Why?
Ergocalciferols
1
2009
1
0.080
Why?
Calcitriol
1
2009
4
0.080
Why?
Phosphorus
1
2009
7
0.080
Why?
HIV Seropositivity
1
2009
51
0.080
Why?
Cilazapril
1
2008
1
0.080
Why?
Reference Values
2
2013
194
0.080
Why?
Glomerulonephritis, IGA
1
2008
9
0.080
Why?
Ovarian Diseases
1
2008
1
0.080
Why?
Publication Bias
1
2008
6
0.080
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2008
25
0.080
Why?
Gadolinium
1
2008
9
0.080
Why?
Kidney Diseases, Cystic
1
2008
2
0.080
Why?
Puerperal Disorders
1
2008
6
0.080
Why?
Radiography, Abdominal
1
2008
5
0.080
Why?
Leuprolide
1
2008
3
0.080
Why?
Menorrhagia
1
2008
3
0.080
Why?
Probability
1
2008
90
0.080
Why?
Renal Insufficiency
1
2008
14
0.080
Why?
Medicaid
1
2008
38
0.080
Why?
Prednisone
1
2008
65
0.080
Why?
Interleukin-8
1
2008
19
0.080
Why?
Antineoplastic Agents, Hormonal
1
2008
18
0.080
Why?
Polycythemia
1
2008
1
0.080
Why?
Fournier Gangrene
1
2008
1
0.080
Why?
Odds Ratio
1
2009
268
0.070
Why?
Sclerosis
1
2008
66
0.070
Why?
Nephrectomy
1
2008
40
0.070
Why?
Disorders of Excessive Somnolence
1
2008
13
0.070
Why?
Hypoglycemia
1
2008
13
0.070
Why?
Interleukin-6
1
2008
79
0.070
Why?
Iatrogenic Disease
1
2008
28
0.070
Why?
Graft Rejection
1
2008
71
0.070
Why?
Arteriovenous Shunt, Surgical
1
2008
23
0.070
Why?
Metabolic Clearance Rate
1
2007
6
0.070
Why?
Angioplasty, Balloon, Coronary
1
2008
40
0.070
Why?
Clinical Competence
1
2010
249
0.070
Why?
Half-Life
1
2007
12
0.070
Why?
Primary Prevention
1
2008
35
0.070
Why?
Biological Availability
1
2007
19
0.070
Why?
Periodicals as Topic
1
2008
43
0.070
Why?
Pregnancy Complications
1
2008
52
0.070
Why?
Cardiac Catheterization
1
2008
72
0.070
Why?
Diffusion of Innovation
1
2007
32
0.070
Why?
Adrenal Cortex Hormones
1
2008
117
0.070
Why?
Hematopoiesis
1
2007
13
0.070
Why?
Ciprofloxacin
1
2007
12
0.070
Why?
Organotechnetium Compounds
1
2007
8
0.070
Why?
Tumor Necrosis Factor-alpha
1
2008
192
0.070
Why?
Patient Dropouts
1
2007
28
0.070
Why?
Anti-Bacterial Agents
1
2010
383
0.070
Why?
Tuberculosis
1
2007
20
0.070
Why?
Pregnancy
1
2008
342
0.070
Why?
Transplantation, Homologous
1
2008
281
0.070
Why?
Bone Diseases
1
2007
25
0.070
Why?
Cause of Death
2
2019
64
0.070
Why?
Morbidity
1
2006
58
0.070
Why?
Caregivers
1
2009
205
0.070
Why?
Proportional Hazards Models
3
2013
352
0.070
Why?
Bias
1
2006
41
0.070
Why?
Fluoroscopy
1
2006
54
0.070
Why?
Mortality
2
2019
90
0.070
Why?
Graft Survival
1
2006
102
0.070
Why?
Inpatients
1
2008
149
0.070
Why?
Catheters, Indwelling
1
2006
24
0.060
Why?
Laparoscopy
1
2008
198
0.060
Why?
Surveys and Questionnaires
2
2009
1216
0.060
Why?
Postoperative Complications
1
2012
932
0.060
Why?
Biomarkers
1
2008
596
0.060
Why?
Cadaver
1
2006
376
0.060
Why?
Causality
1
2005
56
0.060
Why?
Infusions, Intravenous
1
2005
53
0.060
Why?
Histology
1
2004
3
0.060
Why?
Evaluation Studies as Topic
1
2005
37
0.060
Why?
Penis
1
2005
82
0.060
Why?
Patient Care Planning
1
2005
52
0.060
Why?
Melena
1
2004
1
0.060
Why?
Ovum
1
2004
3
0.060
Why?
Embryo, Mammalian
1
2004
24
0.060
Why?
Mesenteric Artery, Superior
1
2004
3
0.060
Why?
Oocytes
1
2004
7
0.060
Why?
Cell Transplantation
1
2004
23
0.060
Why?
Cryopreservation
1
2004
17
0.060
Why?
Nephritis
1
2003
1
0.060
Why?
Nephrosis
1
2003
4
0.060
Why?
Iothalamic Acid
1
2003
2
0.060
Why?
Technetium Tc 99m Pentetate
1
2003
2
0.060
Why?
Iodine Radioisotopes
1
2003
14
0.050
Why?
Crohn Disease
1
2004
41
0.050
Why?
Syndrome
1
2003
82
0.050
Why?
Colitis, Ulcerative
1
2004
64
0.050
Why?
Endoscopy, Gastrointestinal
1
2022
11
0.050
Why?
Nucleosomes
1
2002
3
0.050
Why?
Biopsy, Fine-Needle
1
2022
61
0.050
Why?
Memory
2
2014
302
0.050
Why?
Postoperative Period
1
2003
331
0.050
Why?
Colonoscopy
1
2022
74
0.050
Why?
Autoantibodies
1
2002
80
0.050
Why?
Apoptosis
1
2002
205
0.050
Why?
Rural Population
1
2020
25
0.040
Why?
Myoglobinuria
1
2019
1
0.040
Why?
Carotid Artery, Internal
1
2019
8
0.040
Why?
Magnetic Resonance Angiography
1
2019
31
0.040
Why?
Rhabdomyolysis
1
2019
7
0.040
Why?
Education, Distance
1
2019
18
0.040
Why?
Muscle Weakness
1
2019
34
0.040
Why?
Creatinine
2
2009
53
0.040
Why?
Sperm Motility
1
2018
3
0.040
Why?
Myocardial Revascularization
1
2018
18
0.040
Why?
Organ Size
1
2018
100
0.040
Why?
Mental Health
1
2020
122
0.040
Why?
Cardiovascular Agents
1
2018
28
0.040
Why?
Cerebral Infarction
1
2019
148
0.040
Why?
Age of Onset
1
2018
99
0.040
Why?
Veins
1
2017
9
0.040
Why?
Systole
1
2017
18
0.040
Why?
Longitudinal Studies
2
2014
1384
0.040
Why?
Therapeutic Equivalency
1
2017
2
0.040
Why?
Arteries
1
2017
16
0.040
Why?
Thrombolytic Therapy
1
2018
50
0.040
Why?
Anastomosis, Surgical
1
2017
30
0.040
Why?
Hypertrophy, Left Ventricular
1
2017
25
0.040
Why?
Hypotension
1
2017
29
0.040
Why?
Transferrin
2
2008
6
0.040
Why?
Body Weight
1
2017
144
0.040
Why?
Smoking
1
2018
177
0.030
Why?
Mice, Inbred C57BL
1
2018
435
0.030
Why?
Patient Acuity
1
2016
9
0.030
Why?
Parathyroid Hormone
1
2016
25
0.030
Why?
Image Enhancement
1
2015
49
0.030
Why?
Administration, Intravenous
1
2015
23
0.030
Why?
Cholesterol, HDL
1
2015
28
0.030
Why?
Cholesterol, LDL
1
2015
32
0.030
Why?
Single-Blind Method
1
2015
110
0.030
Why?
Dietary Supplements
1
2015
67
0.030
Why?
Triglycerides
1
2015
61
0.030
Why?
Oliguria
1
2014
1
0.030
Why?
Diuretics
1
2014
6
0.030
Why?
Burns, Chemical
1
2014
2
0.030
Why?
Hypoxia
1
2014
36
0.030
Why?
Sodium-Bicarbonate Symporters
1
2014
1
0.030
Why?
Basal Ganglia Diseases
1
2014
6
0.030
Why?
Imaging, Three-Dimensional
1
2015
199
0.030
Why?
Homozygote
1
2014
21
0.030
Why?
Sequence Deletion
1
2014
15
0.030
Why?
Mice
1
2018
1461
0.030
Why?
Respiration, Artificial
1
2014
114
0.030
Why?
Recurrence
1
2014
322
0.030
Why?
Principal Component Analysis
1
2013
25
0.030
Why?
Sepsis
1
2014
144
0.030
Why?
Mental Status Schedule
1
2013
93
0.030
Why?
Infant
1
2014
587
0.030
Why?
Hemoglobinometry
1
2012
1
0.030
Why?
Linear Models
1
2013
251
0.020
Why?
Drug Delivery Systems
1
2012
31
0.020
Why?
Analysis of Variance
1
2012
269
0.020
Why?
Thailand
1
2009
10
0.020
Why?
Interviews as Topic
1
2009
138
0.020
Why?
Neuropsychological Tests
1
2013
1226
0.020
Why?
Disease Management
1
2009
113
0.020
Why?
Drug Interactions
1
2008
38
0.020
Why?
Health Expenditures
1
2007
18
0.020
Why?
Radionuclide Imaging
1
2007
43
0.020
Why?
Osteomyelitis
1
2007
20
0.020
Why?
False Positive Reactions
1
2007
36
0.020
Why?
Equipment Failure
1
2006
39
0.020
Why?
Costs and Cost Analysis
1
2006
35
0.020
Why?
Demography
1
2006
73
0.020
Why?
Ambulatory Care
1
2006
74
0.020
Why?
Singh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (540)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_